Reshma Kewalramani, CEO & President: Vertex Pharmaceuticals VRTX Buy · Filed 25/08/07

Trade details

Type: Insider buy
Amount: $1,669,153.2
Shares · price: 4,290 sh · $389.08 a share
Held after: 110,258 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Reshma KewalramaniCEO & President
Trade date: 25/08/06
Filed: 25/08/07
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +4.0%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/07/07~25/09/05

Reshma Kewalramani's recent trades

Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.7M
15,580 sh
$7.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3M
5,995 sh
$3M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.7M
3,498 sh
$1.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,278 sh
$1.6M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,725 sh
$1.3M
Filed 03/03
Traded 02/27

Reshma Kewalramani, CEO — bought $1.7M of Vertex Pharmaceuticals VRTX · 4,290 sh @ $389.08 | Whalegun